MyAverix Finance
SHG · Healthcare
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443)
Biotechnology
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $9.57B, P/E ratio is 18.00, net margin is -232.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688443
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) — FAQ
What is Chongqing Genrix Biopharmaceutical Co. Ltd. A's market cap?
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) has a reported market cap of $9.57B (data as of 2026-03-29).
What is 688443's P/E ratio?
The price-to-earnings (P/E) ratio for Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) is 18.00 (data as of 2026-03-29).
Does Chongqing Genrix Biopharmaceutical Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443). Check the MyAverix Finance app for the latest dividend data.
What sector is Chongqing Genrix Biopharmaceutical Co. Ltd. A in?
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688443 listed on?
688443 is listed on SHG.
What is Chongqing Genrix Biopharmaceutical Co. Ltd. A's net margin?
Chongqing Genrix Biopharmaceutical Co. Ltd. A (688443) reports a net margin of -232.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.